Cardiol Therapeutics (CRDL) Change in Receivables (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Change in Receivables of -$10463.4 for Q1 2026, up 19.97% on a QoQ basis from -$13074.6 in Q4 2025, and down 161.52% year-over-year from $17008.9 in Q1 2025.
Cardiol Therapeutics (CRDL) Change in Receivables (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Change in Receivables history runs 7 years deep, the most recent figure standing at -$10463.4 for Q1 2026.
- Quarterly Change in Receivables fell 161.52% year-over-year to -$10463.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4328.9 (down 92.4% YoY) and the FY2025 annual result came in at $32010.0, up 5.51% from the prior year.
- Change in Receivables was -$10463.4 for Q1 2026 at Cardiol Therapeutics, up from -$13074.6 in the prior quarter.
- Across five years, Change in Receivables topped out at $44105.3 in Q2 2024 and bottomed at -$41111.7 in Q4 2022.
- A 5-year average of -$440.58 and a median of $7058.9 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 985.38% — and 2024, when it soared 524.82%.
- Cardiol Therapeutics' Change in Receivables stood at -$41111.7 in 2022, then surged by 162.97% to $25888.7 in 2023, then tumbled by 219.69% to -$30987.0 in 2024, then jumped by 57.81% to -$13074.6 in 2025, then increased by 19.97% to -$10463.4 in 2026.
- Business Quant data shows CRDL's Change in Receivables at -$10463.4 in Q1 2026, -$13074.6 in Q4 2025, and $15569.6 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | -10,463.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,463.37 |
| Mar 31, 2026 | -10,463.37 |
| Dec 31, 2025 | -13,074.63 |
| Dec 31, 2025 | -13,074.63 |
| Sep 30, 2025 | 15,569.61 |
| Sep 30, 2025 | 15,569.61 |
| Jun 30, 2025 | 12,297.26 |
| Jun 30, 2025 | 12,297.26 |
| Mar 31, 2025 | 17,008.94 |
| Mar 31, 2025 | 17,008.94 |
| Dec 31, 2024 | -30,986.96 |
| Dec 31, 2024 | -30,986.96 |
| Sep 30, 2024 | 26,809.23 |
| Sep 30, 2024 | 26,809.23 |
| Jun 30, 2024 | 44,105.32 |
| Jun 30, 2024 | 44,105.32 |
| Mar 31, 2024 | -8,333.93 |
| Mar 31, 2024 | -8,333.93 |
| Dec 31, 2023 | 25,888.70 |
| Dec 31, 2023 | 25,888.70 |